뇌졸중 원격의료(텔레스트로크) 시장 규모, 점유율과 동향 분석 리포트 : 유형별, 용도별, 컴포넌트별, 제공 형태별, 최종 용도별, 지역별, 부문 예측(2025-2033년)

Telestroke Market Summary

The global telestroke market size was estimated at USD 1.77 billion in 2024 and is projected to reach USD 5.49 billion by 2033, growing at a CAGR of 13.15% from 2025 to 2033. Rising incidence of stroke is anticipated to boost market growth.

According to an Institute for Health Metrics and Evaluation article published in September 2024, it was estimated that nearly 11.9 million new stroke cases occurred worldwide in 2021, encompassing both ischemic and hemorrhagic types. This rising incidence highlights the growing need for timely intervention and specialist care, especially given the challenges of limited access to neurologists in many regions.

Telestroke solutions directly address this gap by enabling rapid remote consultations, faster diagnosis, and improved treatment pathways for patients regardless of their location. While the disease continues to rank among the leading causes of disability and death globally, the increasing patient volume is creating strong momentum for the adoption of telestroke services, positioning the market for sustained growth.

Moreover, as per the WHO article published in August 2025, heart attacks and strokes together account for over four-fifths of all cardiovascular-related deaths, and strikingly, about one-third of these fatalities occur in people under the age of 70. This high rate of premature mortality underlines the critical importance of timely intervention in stroke management. Telestroke services are emerging as a powerful solution to this challenge, as they enable rapid access to specialist care regardless of geographic barriers. Connecting patients in community hospitals or rural settings with neurologists through real-time digital platforms and telestroke systems can accelerate diagnosis and treatment, helping to reduce avoidable deaths and improve long-term recovery outcomes.

Rising shortage of neurologists and unequal access to stroke care drive market growth. According to the Cleveland Clinic Article published in January 2024, access to neurologists in the U.S. is markedly uneven, with rural and micropolitan communities facing the greatest challenges. In these areas, patients have substantially reduced access to specialized care studies indicate rural residents experience more than 80% lower access, and those in micropolitan regions over 60% lower access, compared to urban populations. This disparity often leads to delayed diagnosis and treatment for stroke patients, increasing the risk of severe complications or death. Telestroke services address this critical gap by connecting hospitals in underserved regions with neurologists in real time, enabling rapid evaluation, diagnosis, and initiation of therapy. Overcoming geographic barriers, telestroke programs are improving clinical outcomes and expanding equitable access to life-saving care across the country.

Global Telestroke Market Report Segmentation

This report forecasts revenue and volume growth at global, regional, and country levels and analyzes industry trends in each sub-segments from 2021 to 2033. For this study, Grand View Research, Inc. has segmented the global telestroke market report based on type, application, component, delivery mode, end use, and region:

• Type Outlook (Revenue USD Million, 2021 - 2033)
• Ischemic Stroke
• Hemorrhagic Stroke
• Transient Ischemic Attack
• Application Outlook (Revenue USD Million, 2021 - 2033)
• Counseling
• Diagnosis
• Monitoring
• Emergency Services
• Others
• Component Outlook (Revenue USD Million, 2021 - 2033)
• Hardware
• Software/Platform
• Services
• Delivery Mode Outlook (Revenue USD Million, 2021 - 2033)
• Cloud-based
• On-premise
• Web/Mobile
• End Use Outlook (Revenue USD Million, 2021 - 2033)
• Hospital
• Speciality Clinic
• Others
• Regional Outlook Revenue USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Spain
  • Italy
  • France
  • Denmark
  • Norway
  • Sweden
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Thailand
  • South Korea
• Latin America
  • Brazil
  • Argentina
• MEA
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Segment scope
  • 1.1.2. Regional scope
  • 1.1.3. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.1.1. Approach 1: Commodity flow approach
• 1.7. Research Assumptions
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Type outlook
  • 2.2.2. Application outlook
  • 2.2.3. Component outlook
  • 2.2.4. Delivery mode outlook
  • 2.2.5. End use outlook
  • 2.2.6. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Telestroke Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Increasing stroke cases
    • 3.2.1.2. Growing awareness among the population for stroke care
    • 3.2.1.3. Technological advancements for the telestroke
    • 3.2.1.4. Government initiatives and funding
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. High implementation and maintenance costs of telestroke systems
    • 3.2.2.2. Limited specialist availability and unequal access to services
    • 3.2.2.3. Connectivity gaps in rural and remote regions
• 3.3. Telestroke: Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
  • 3.3.2. PESTLE Analysis
• 3.4. Regulatory Framework
• 3.5. Technology Landscape
  • 3.5.1. Technological advancements driving telecare
  • 3.5.2. Telestroke software and applications
  • 3.5.3. Data analytics and artificial intelligence
  • 3.5.4. Wearable devices and IoT integration
  • 3.5.5. Telecommunication infrastructure
• 3.6. Funding Scenario
• 3.7. Case Study Analysis

Chapter 4. Telestroke Market Segment Analysis, By Type, 2021 - 2033 (USD Million)

• 4.1. Definition and Scope
• 4.2. Type Market Share Analysis, 2024 & 2033
• 4.3. Segment Dashboard
• 4.4. Global Telestroke Market, by Type, 2021 to 2033
• 4.5. Ischemic Stroke
  • 4.5.1. Ischemic stroke market estimates and forecasts, 2021 - 2033 (USD Million)
• 4.6. Hemorrhagic Stroke
  • 4.6.1. Hemorrhagic stroke market estimates and forecasts, 2021 - 2033 (USD Million)
• 4.7. Transient Ischemic Attack
  • 4.7.1. Transient ischemic attack market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 5. Telestroke Market Segment Analysis, By Application, 2021 - 2033 (USD Million)

• 5.1. Definition and Scope
• 5.2. Application Market Share Analysis, 2024 & 2033
• 5.3. Segment Dashboard
• 5.4. Global Telestroke Market, by Application, 2021 to 2033
• 5.5. Counseling
  • 5.5.1. Counseling market estimates and forecasts, 2021 - 2033 (USD Million)
• 5.6. Diagnosis
  • 5.6.1. Diagnosis market estimates and forecasts, 2021 - 2033 (USD Million)
• 5.7. Monitoring
  • 5.7.1. Monitoring market estimates and forecasts, 2021 - 2033 (USD Million)
• 5.8. Emergency Services
  • 5.8.1. Emergency services market estimates and forecasts, 2021 - 2033 (USD Million)
• 5.9. Others
  • 5.9.1. Others market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 6. Telestroke Market Segment Analysis, By Component, 2021 - 2033 (USD Million)

• 6.1. Definition and Scope
• 6.2. Component Market Share Analysis, 2024 & 2033
• 6.3. Segment Dashboard
• 6.4. Global Telestroke Market, by Component, 2021 to 2033
• 6.5. Hardware
  • 6.5.1. Hardware market estimates and forecasts, 2021 - 2033 (USD Million)
• 6.6. Software/Platform
  • 6.6.1. Software/platform market estimates and forecasts, 2021 - 2033 (USD Million)
• 6.7. Services
  • 6.7.1. Services market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 7. Telestroke Market Segment Analysis, By Delivery Mode, 2021 - 2033 (USD Million)

• 7.1. Definition and Scope
• 7.2. Delivery Mode Market Share Analysis, 2024 & 2033
• 7.3. Segment Dashboard
• 7.4. Global Telestroke Market, by Delivery Mode, 2021 to 2033
• 7.5. Cloud-based
  • 7.5.1. Cloud-based market estimates and forecasts, 2021 - 2033 (USD Million)
• 7.6. On-premise
  • 7.6.1. On-premise market estimates and forecasts, 2021 - 2033 (USD Million)
• 7.7. Web/Mobile
  • 7.7.1. Web/mobile market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 8. Telestroke Market Segment Analysis, By End Use, 2021 - 2033 (USD Million)

• 8.1. Definition and Scope
• 8.2. End Use Market Share Analysis, 2024 & 2033
• 8.3. Segment Dashboard
• 8.4. Global Telestroke Market, by End Use, 2021 to 2033
• 8.5. Hospitals
  • 8.5.1. Hospitals market estimates and forecasts, 2021 - 2033 (USD Million)
• 8.6. Specialty Clinics
  • 8.6.1. Specialty clinics market estimates and forecasts, 2021 - 2033 (USD Million)
• 8.7. Others
  • 8.7.1. Others market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 9. Telestroke Market Segment Analysis, By Region, By Type, By Application, By End Use, 2021 - 2033 (USD Million)

• 9.1. Regional Market Share Analysis, 2024 & 2033
• 9.2. Regional Market Dashboard
• 9.3. Regional Market Snapshot
• 9.4. Telestroke Market Share by Region, 2024 & 2033:
• 9.5. North America
  • 9.5.1. North America telestroke market, 2021 - 2033 (USD Million)
  • 9.5.2. U.S.
    • 9.5.2.1. Key country dynamics
    • 9.5.2.2. Regulatory Scenario
    • 9.5.2.3. Competitive Scenario
    • 9.5.2.4. U.S. telestroke market, 2021 - 2033 (USD Million)
  • 9.5.3. Canada
    • 9.5.3.1. Key country dynamics
    • 9.5.3.2. Regulatory Scenario
    • 9.5.3.3. Competitive Scenario
    • 9.5.3.4. Canada telestroke market, 2021 - 2033 (USD Million)
  • 9.5.4. Mexico
    • 9.5.4.1. Key country dynamics
    • 9.5.4.2. Regulatory Scenario
    • 9.5.4.3. Competitive Scenario
    • 9.5.4.4. Mexico telestroke market, 2021 - 2033 (USD Million)
• 9.6. Europe
  • 9.6.1. Europe telestroke market, 2021 - 2033 (USD Million)
  • 9.6.2. UK
    • 9.6.2.1. Key country dynamics
    • 9.6.2.2. Regulatory Scenario
    • 9.6.2.3. Competitive Scenario
    • 9.6.2.4. UK telestroke market, 2021 - 2033 (USD Million)
  • 9.6.3. Germany
    • 9.6.3.1. Key country dynamics
    • 9.6.3.2. Regulatory Scenario
    • 9.6.3.3. Competitive Scenario
    • 9.6.3.4. Germany telestroke market, 2021 - 2033 (USD Million)
  • 9.6.4. France
    • 9.6.4.1. Key country dynamics
    • 9.6.4.2. Regulatory Scenario
    • 9.6.4.3. Competitive Scenario
    • 9.6.4.4. France telestroke market, 2021 - 2033 (USD Million)
  • 9.6.5. Italy
    • 9.6.5.1. Key country dynamics
    • 9.6.5.2. Regulatory Scenario
    • 9.6.5.3. Competitive Scenario
    • 9.6.5.4. Italy telestroke market, 2021 - 2033 (USD Million)
  • 9.6.6. Spain
    • 9.6.6.1. Key country dynamics
    • 9.6.6.2. Regulatory Scenario
    • 9.6.6.3. Competitive Scenario
    • 9.6.6.4. Spain telestroke market, 2021 - 2033 (USD Million)
  • 9.6.7. Norway
    • 9.6.7.1. Key country dynamics
    • 9.6.7.2. Regulatory Scenario
    • 9.6.7.3. Competitive Scenario
    • 9.6.7.4. Norway telestroke market, 2021 - 2033 (USD Million)
  • 9.6.8. Sweden
    • 9.6.8.1. Key country dynamics
    • 9.6.8.2. Regulatory Scenario
    • 9.6.8.3. Competitive Scenario
    • 9.6.8.4. Sweden telestroke market, 2021 - 2033 (USD Million)
  • 9.6.9. Denmark
    • 9.6.9.1. Key country dynamics
    • 9.6.9.2. Regulatory Scenario
    • 9.6.9.3. Competitive Scenario
    • 9.6.9.4. Denmark telestroke market, 2021 - 2033 (USD Million)
• 9.7. Asia Pacific
  • 9.7.1. Japan
    • 9.7.1.1. Key country dynamics
    • 9.7.1.2. Regulatory Scenario
    • 9.7.1.3. Competitive Scenario
    • 9.7.1.4. Japan telestroke market, 2021 - 2033 (USD Million)
  • 9.7.2. China
    • 9.7.2.1. Key country dynamics
    • 9.7.2.2. Regulatory Scenario
    • 9.7.2.3. Competitive Scenario
    • 9.7.2.4. China telestroke market, 2021 - 2033 (USD Million)
  • 9.7.3. India
    • 9.7.3.1. Key country dynamics
    • 9.7.3.2. Regulatory Scenario
    • 9.7.3.3. Competitive Scenario
    • 9.7.3.4. India telestroke market, 2021 - 2033 (USD Million)
  • 9.7.4. Australia
    • 9.7.4.1. Key country dynamics
    • 9.7.4.2. Regulatory Scenario
    • 9.7.4.3. Competitive Scenario
    • 9.7.4.4. Australia telestroke market, 2021 - 2033 (USD Million)
  • 9.7.5. South Korea
    • 9.7.5.1. Key country dynamics
    • 9.7.5.2. Regulatory Scenario
    • 9.7.5.3. Competitive Scenario
    • 9.7.5.4. South Korea telestroke market, 2021 - 2033 (USD Million)
  • 9.7.6. Thailand
    • 9.7.6.1. Key country dynamics
    • 9.7.6.2. Regulatory Scenario
    • 9.7.6.3. Competitive Scenario
    • 9.7.6.4. Thailand telestroke market, 2021 - 2033 (USD Million)
• 9.8. Latin America
  • 9.8.1. Brazil
    • 9.8.1.1. Key country dynamics
    • 9.8.1.2. Regulatory Scenario
    • 9.8.1.3. Competitive Scenario
    • 9.8.1.4. Brazil telestroke market, 2021 - 2033 (USD Million)
  • 9.8.2. Argentina
    • 9.8.2.1. Key country dynamics
    • 9.8.2.2. Regulatory Scenario
    • 9.8.2.3. Competitive Scenario
    • 9.8.2.4. Argentina telestroke market, 2021 - 2033 (USD Million)
• 9.9. MEA
  • 9.9.1. South Africa
    • 9.9.1.1. Key country dynamics
    • 9.9.1.2. Regulatory Scenario
    • 9.9.1.3. Competitive Scenario
    • 9.9.1.4. South Africa telestroke market, 2021 - 2033 (USD Million)
  • 9.9.2. Saudi Arabia
    • 9.9.2.1. Key country dynamics
    • 9.9.2.2. Regulatory Scenario
    • 9.9.2.3. Competitive Scenario
    • 9.9.2.4. Saudi Arabia telestroke market, 2021 - 2033 (USD Million)
  • 9.9.3. UAE
    • 9.9.3.1. Key country dynamics
    • 9.9.3.2. Regulatory Scenario
    • 9.9.3.3. Competitive Scenario
    • 9.9.3.4. UAE telestroke market, 2021 - 2033 (USD Million)
  • 9.9.4. Kuwait
    • 9.9.4.1. Key country dynamics
    • 9.9.4.2. Regulatory Scenario
    • 9.9.4.3. Competitive Scenario
    • 9.9.4.4. Kuwait telestroke market, 2021 - 2033 (USD Million)

Chapter 10. Competitive Landscape

• 10.1. Recent Developments & Impact Analysis, By Key Market Participants
• 10.2. Company Categorization
• 10.3. Company Profiles
  • 10.3.1. Sevaro Health, Inc.
    • 10.3.1.1. Company overview
    • 10.3.1.2. Financial performance
    • 10.3.1.3. Product benchmarking
    • 10.3.1.4. Strategic initiatives
  • 10.3.2. Teladoc Health, Inc.
    • 10.3.2.1. Company overview
    • 10.3.2.2. Financial performance
    • 10.3.2.3. Product benchmarking
    • 10.3.2.4. Strategic initiatives
  • 10.3.3. TeleSpecialists
    • 10.3.3.1. Company overview
    • 10.3.3.2. Financial performance
    • 10.3.3.3. Product benchmarking
    • 10.3.3.4. Strategic initiatives
  • 10.3.4. CEP AMERICA, LLC
    • 10.3.4.1. Company overview
    • 10.3.4.2. Financial performance
    • 10.3.4.3. Product benchmarking
    • 10.3.4.4. Strategic initiatives
  • 10.3.5. Providence
    • 10.3.5.1. Company overview
    • 10.3.5.2. Financial performance
    • 10.3.5.3. Product benchmarking
    • 10.3.5.4. Strategic initiatives
  • 10.3.6. Lakewood Health System
    • 10.3.6.1. Company overview
    • 10.3.6.2. Financial performance
    • 10.3.6.3. Product benchmarking
    • 10.3.6.4. Strategic initiatives
  • 10.3.7. T SQRD, Inc.
    • 10.3.7.1. Company overview
    • 10.3.7.2. Financial performance
    • 10.3.7.3. Product benchmarking
    • 10.3.7.4. Strategic initiatives
  • 10.3.8. Access TeleCare, LLC
    • 10.3.8.1. Company overview
    • 10.3.8.2. Financial performance
    • 10.3.8.3. Product benchmarking
    • 10.3.8.4. Strategic initiatives
  • 10.3.9. Blue Sky Telehealth
    • 10.3.9.1. Company overview
    • 10.3.9.2. Financial performance
    • 10.3.9.3. Product benchmarking
    • 10.3.9.4. Strategic initiatives
  • 10.3.10. American TelePhysicians
    • 10.3.10.1. Company overview
    • 10.3.10.2. Financial performance
    • 10.3.10.3. Product benchmarking
    • 10.3.10.4. Strategic initiatives
  • 10.3.11. American Well. Amwell
    • 10.3.11.1. Company overview
    • 10.3.11.2. Financial performance
    • 10.3.11.3. Product benchmarking
    • 10.3.11.4. Strategic initiatives
  • 10.3.12. Equum Medical
    • 10.3.12.1. Company overview
    • 10.3.12.2. Financial performance
    • 10.3.12.3. Product benchmarking
    • 10.3.12.4. Strategic initiatives